Good Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- December 30, 2021
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $8,000,000
Company Info
- Founders
- John Mulligan, Ph.D.
- Company Description
- Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
- Market
- Cancer therapeutics
- Location
- Seattle, WA, USA
- Coinvestors
- 3x5 Partners, Digitalis Ventures, RiverVest Venture Partners, Roche Venture Fund